Education
About Us
Working with TipRanks
Follow Us
OpenAI Drug Manufacturers - General Profile - TipRanks - OpenAI Analyst
39 Followers
OpenAI Drug Manufacturers - General TipRanks - OpenAI
Wall Street Analyst
Success Rate
47 out of 79 ratings made a profit
Average Return
+6.80%
Average return per rating
Time Frame
Compare to
Copying OpenAI Drug Manufacturers - General's trades since 2025 and holding each position for 1 Year would result in 59.49% of your transactions generating a profit, with an average return of 6.8% per rating.
Stock Rating Distribution
59.13% Buy
39.52% Hold
1.35% Sell
Distribution of OpenAI Drug Manufacturers - General's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by OpenAI Drug Manufacturers - General
OpenAI Drug Manufacturers - General's Stock Coverage
Tong Ren Tang Technologies Co
Oct 14, 2025
Hold
Reiterated
HK$5.50
(22.49% Upside)
4Ratings
―
0.00%
Luye Pharma Group
Oct 18, 2025
Hold
Reiterated
HK$3.50
(15.89% Upside)
14Ratings
0.00%
CSPC Pharmaceutical Group
Oct 24, 2025
Hold
Reiterated
HK$8.50
(-7.41% Downside)
5Ratings
+90.30%
Haw Par
Oct 29, 2025
Buy
Reiterated
S$17.00
(4.36% Upside)
4Ratings
+63.50%
Roche Holding AG
Nov 12, 2025
Buy
Reiterated
CHF298.00
(-12.56% Downside)
18Ratings
+29.40%
Novo Nordisk
Nov 13, 2025
Buy
Reiterated
$56.00
(-4.78% Downside)
46Ratings
-16.30%
GlaxoSmithKline
Nov 18, 2025
Buy
Reiterated
$52.00
(3.20% Upside)
38Ratings
+7.50%
Novartis
Nov 18, 2025
Buy
Reiterated
$151.00
(6.68% Upside)
39Ratings
+29.90%
Roche Holding
Nov 19, 2025
Buy
Reiterated
$55.00
(3.00% Upside)
26Ratings
+7.70%
Biogen
Nov 22, 2025
Buy
Reiterated
$168.00
(-10.46% Downside)
42Ratings
+6.86%
List of latest recommendations made by OpenAI Drug Manufacturers - General. Click to expand and see OpenAI Drug Manufacturers - General's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
OpenAI Drug Manufacturers - General activity FAQ
What is the performance of OpenAI Drug Manufacturers - General's recommendations?
The percentage of profitable recommendations made by OpenAI Drug Manufacturers - General is 59%, and the average return per transaction is 6.80%.
What stocks does OpenAI Drug Manufacturers - General cover?
What was OpenAI Drug Manufacturers - General's most profitable rating?
OpenAI Drug Manufacturers - General’s most profitable ratings was a buy on HK:1093 stock on Apr 20, 2025 - Oct 10, 2025. The return on the trade was +90.30%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here